| Literature DB >> 21266081 |
Diana Panesso1, Maria C Montealegre, Sandra Rincón, Maria F Mojica, Louis B Rice, Kavindra V Singh, Barbara E Murray, Cesar A Arias.
Abstract
BACKGROUND: Plasmids containing hylEfm (pHylEfm) were previously shown to increase gastrointestinal colonization and lethality of Enterococcus faecium in experimental peritonitis. The hylEfm gene, predicting a glycosyl hydrolase, has been considered as a virulence determinant of hospital-associated E. faecium, although its direct contribution to virulence has not been investigated. Here, we constructed mutants of the hylEfm-region and we evaluated their effect on virulence using a murine peritonitis model.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21266081 PMCID: PMC3039558 DOI: 10.1186/1471-2180-11-20
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
E. faecium strains and plasmids used in this work
| Strains/Plasmids | Relevant Characteristics | Reference |
|---|---|---|
| TX16 (DO) | Sequenced endocarditis clinical isolate, Emr, Smr. ST-16a | [ |
| TX1330RF | Fsr and Rfr derivative of TX1330, a faecal colonizing strain from a healthy human volunteer | [ |
| TX1330RF (pHylEfmTX16) | Derivative of TX1330RF to which the | [ |
| TX1330RF (pHylEfmTX16Δ7,534) | Mutant with deletion of part or all of 6 genes of the | This work |
| TX1330RF (pHylEfmTX16Δ4genes) | Non-polar deletion of 4 genes of the | This work |
| TX1330RF (pHylEfmTX16Δ | Non-polar deletion mutant of | This work |
| TX1330RF (pHylEfmTX16Δ | Non-polar deletion of | This work |
| TX1330RF (pHylEfmTX16Δ | Non-polar deletion of the gene downstream of | This work |
| CK111 | OG1Sp | [ |
| pHylEfmTX16 | Conjugative and transferable megaplasmid (ca. 250 kb) of TX16 (DO) containing | [ |
| pCJK47 | Conjugative donor plasmid for markerless mutagenesis; | [ |
| pHOU1 | Derivative of pCJK47 in which the | This work |
| pHOU2 | Derivative of pCJK47 in which the | This work |
| pTEX5501ts | [ | |
| pAT392 | [ | |
| pAT392:: | Derivative of pAT392 containing | This work |
| pAT392:: | Derivative of pAT392 containing both the | This work |
Emr, erythromycin resistance; Fsr, fusidic acid resistance; Gmr, gentamicin resistance, Rfr, rifampin resistance; Smr, high-level resistance to streptomycin. aST refers to sequence type after multi-locus sequence typing. ST16 is part of CC17
Figure 1Physical map of the -region in pHyl. The annotated predicted function of the corresponding genes is shown above the genes. The genes were divided into three groups (metabolism, transport [in gray] and regulation based on putative functions). Strain nomenclature follows that specified in Table 1. Black arrows above the genes indicate the position of the primers used to obtain DNA fragments for mutagenesis and follow the nomenclature of Table 2. The crosses depict the genes that were deleted. The asterisks indicate only partial deletion of the gene was obtained. The number refers to the glycosyl hydrolase family with hyldepicted in bold; allelic replacement with the chloramphenicol acetyl transferase gene (cat) was performed. NA, not applicable.
Primers used in this work
| Primer | Sequence (5'-3') | Relevant Characteristics |
|---|---|---|
| A | ga | Forward, BglII site (underlined), used amplification of |
| B | cca | Reverse, NsiI site (underlined), used amplification of |
| C | cgg | Forward, BamHI site (underlined), located 1,251 nucleotides upstream of the start codon of the gene encoding a putative glycosyl hydrolase family 20 (Figure 1.) |
| D | ccg | Reverse, XhoI site (underlined), located 294 nucleotides upstream of the start codon of the gene encoding a putative glycosyl hydrolase family 20 (Figure 1.) |
| E | cga | Forward, ApaI site (underlined); located 592 nucleotides downstream of the |
| F | ccg | Reverse, EcoRI site, 1,571 nucleotides downstream of the |
| G | gc | Forward, SacI site (underlined), ribosomal binding site of |
| H | tcc | Reverse, SmaI site, (underlined) and stop codon of |
| I | tcc | Reverse, SmaI site (underlined), stop codon of |
| J | cg | Forward, BamH site (underlined) 438 nucleotides upstream of the stop codon of carbohydrate ABC transporter gene (Figure 1.) |
| K | gcggccgctcgagggcccttagtgcgattgtatctgac | Reverse, stop codon of the gene that encodes to transmembrane protein (Figure 1.) |
| L | Forward, ApaI, XhoI, NotI site, stop codon | |
| M | c | Reverse, NsiI site, 1,091 nucleotides upstream of stop codon of GMP synthase (opposite orientation) (Figure 1.) |
| N | ccg | Forward, EcoRI site (underlined), located 2,138 nucleotides down-stream of glycosyl hidrolase family 45-2 start codon (Figure 1.) |
| O | tcatctattttctcctttgaaagtaatcactatattcc | Reverse, stop codon of glycosyl hydrolase family 45-2 (Figure 1.) |
| P | tcaaaggagaaaatagatgaatatcttaaaaaataaaaagc | Forward, located 40 nucleotides upstream of |
| Q | ataagaat | Reverse, NotI site (underlined), stop codon of |
| R | ataagaat | Forward, NotI site (underlined), located 2,138 nucleotides down-stream of glycosyl hydrolase family 45-2 start codon (Figure 1.) |
| S | tcatctattttctcctttgaaagtaatcactatattcc | Reverse, stop codon of glycosyl hydrolase family 45-2 (Figure 1.) |
| T | tcaaaggagaaaatagatgacaaaattaaataaaaaatgg | Forward, 1,973 nucleotides upstream of stop codon of GMP synthase (Figure 1.) |
| U | cg | Reverse, EcoRI site (underlined), 994 nucleotides upstream of start codon of GMP synthase (opposite direction) (Figure 1.) |
| V | aaggaaaaaa | Forward, NotI site (underlined), 902 nucleotides downstream of |
| W | tttgttctcctttttcttgctttttattttttaag | Reverse, stop codon of of |
| X | gcaagaaaaaggagaacaaacaaaattaaataaaaaatgg | Forward, 1,973 nucleotides upstream of stop codon of GMP synthase (opposite direction) (Figure 1.) |
| Y | ccg | Reverse, EcoRI site (underlined), 1,094 nucleotides upstream of stop codon of GMP synthase (opposite direction) (Figure 1.) |
| A1 | cgcgtcgtattaaaaatcat | Forward, 143 nucleotides upstream of stop codon of GH20 (Figure 3.) |
| A2 | gatcgataaactggctcgt | Reverse, 139 nucleotides upstream of start codon of GH42 (Figure 3.) |
| B1 | acgc | Forward, SalI site (underlined), 2,316 nucleotides downstream of start codon of GH42 (Figure 3.) |
| B2 | ggaa | Reverse, BglII site (underlined), 159 nucleotides downstream of start codon of |
| C1 | gttagaagaagtctggaaaccg | Forward, 138 nucleotides downstream of start codon of |
| C2 | tgctaagatattcctctactcg | Reverse, 798 nucleotides upstream of stop codon of |
| D1 | acat | Forward, SphI site (underlined), 169 nucleotides upstream of stop codon of |
| D2 | cg | Reverse, EcoRI site (underlined), 319 nucleotides upstream of stop codon of |
| E1 | gcaaggcttcttagaga | Forward, |
| E2 | catcgtgtaagctaacttc | Reverse, |
Figure 2Physical map of the plasmids pHOU1 and pHOU2 for targeted mutagenesis of . A, plasmid used for construction of TX1330RF (pHylEfmTX16Δ4genes), TX1330RF(pHylEfmTX16Δ), TX1330RF(pHylEfmTX16Δ) and TX1330RF (pHylEfmTX16Δ) deletion mutants (Figure 1); B, plasmid used for construction of the TX1330RF(pHylEfmTX16Δ7,534) deletion mutant (Figure 1)
Figure 3Transcriptional analysis of genes in the region using reverse transcriptase (RT)-PCR. A, physical map of the hylregion and primers used for RT-PCR experiments. Black arrows above the genes indicate the position of the primers used to amplify DNA sequences from the cDNA obtained after reverse transcription. B, RT-PCR using primers A1-A2; C, RT-PCR using primes B1-B2; D, RT-PCR using primers C1-C2; E, RT-PCR using primers D1-D2; F, RT-PCR with ddl as the target gene using primers E1-E2 (Table 2) [32,33]. Lanes 1 and 2, TX1330RF (RT-PCR reaction and control without RT enzyme, respectively); lanes 3 and 4, TX1330RF(pHylEfm16) (RT-PCR reaction and control without RT enzyme, respectively); lanes 5 and 6 TX16(pHylEfm16) (RT-PCR reaction and control without RT enzyme respectively). The molecular weight of the bands is indicated to the right.
Figure 4Growth and survival curves in the mouse peritonitis model of ) and TX1330RF(pHyl), carrying an intact -region, and pHyl(6 gene mutant of the -region). A, Survival curve of representative inoculum (5 inocula per experiment in two independent experiments) of TX0016(pHylEfmTX16) vs TX0016(pHylEfmTX16Δ7,534) in mouse peritonitis; B, growth curves of TX1330RF(pHylEfmTX16) vs TX1330RF(pHylEfmTX16Δ7,534) and a second transconjugant [TX1330RF(pHylEfmTX16Δ7,534)-TCII] obtained from the same mating experiment between TX16(pHylEfmTX16Δ7,534) and TX1330RF, expressed as optical density (A600) in brain heart infusion (BHI) broth (results of at least three experiments per strain). C and D, survival curves of TX1330RF(pHylEfmTX16) vs TX1330RF(pHylEfmTX16Δ7,534) obtained in the peritonitis model at different inocula in independent experiments performed at different days.
Figure 5Survival curves in the mouse peritonitis model of . A and B show survival curves of the TX1330RF(pHylEfmTX16Δ7,534) (6 gene mutant in the hylregion) complemented with pAT392-derivatives (which include pAT392::hyland pAT392::hyl-down) obtained in the peritonitis model at different inocula in independent experiments performed at different days. The asterisk indicates that the lines are superimposed since values are identical.
Figure 6Survival curves in the mouse peritonitis model of ) and deletion mutants (Figure 1 and Table 1) showing representative inocula (5 inocula per each experiment). A, TX1330RF(pHylEfmTX16) vs TX1330RF(pHylEfmTX16Δ4genes); B, TX1330RF(pHylEfmTX16) vs TX1330RF (pHylEfmTX16Δhyl); C, TX1330RF(pHylEfmTX16) vs TX1330RF(pHylEfmTX16Δ); D, TX1330RF(pHylEfmTX16) vs TX1330RF(pHylEfmTX16Δ)